Vertex Pharmaceuticals
Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VRTX
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.
VRTX Key Statistics
Stock Snapshot
As of today, Vertex Pharmaceuticals(VRTX) shares are valued at $476.00. The company's market cap stands at 121B, with a P/E ratio of 33.01.
As of 2026-01-26, Vertex Pharmaceuticals(VRTX) stock has fluctuated between $468.43 and $479.08. The current price stands at $476.00, placing the stock +1.6% above today's low and -0.6% off the high.
The Vertex Pharmaceuticals(VRTX)'s current trading volume is 1.67M, compared to an average daily volume of 1.59M.
During the past year, Vertex Pharmaceuticals(VRTX) stock moved between $362.50 at its lowest and $519.68 at its peak.
During the past year, Vertex Pharmaceuticals(VRTX) stock moved between $362.50 at its lowest and $519.68 at its peak.
VRTX News
UBS raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $545 from $535 and keeps a Buy rating on the shares. The U.S. Pharmaceuticals and Biotech...
Vertex Pharmaceuticals (NasdaqGS:VRTX) received FDA approval for CASGEVY, a CRISPR/Cas9 gene edited therapy for transfusion dependent beta thalassemia. The dec...
On CNBC's “Halftime Report Final Trades,” Jim Lebenthal, partner at Cerity Partners, said Vertex Pharmaceuticals (NASDAQ:VRTX) has nice little chart here over t...
Analyst ratings
69%
of 36 ratingsMore VRTX News
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) shares are trending on Thursday. Shares of the Massachusetts-based biotech company, which gained 4.31% during Wednesd...
Recent analyst moves have put Vertex Pharmaceuticals (VRTX) back in focus, with Bernstein upgrading the stock and UBS initiating coverage. Both firms point to c...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.